News >

Frontline Findings Put Fresh Focus on Immunotherapy in NSCLC

Silas Inman @silasinman
Published: Wednesday, Dec 20, 2017

Solange Peters, MD, PhD

Solange Peters, MD, PhD
Findings from the phase III IMpower150 study have placed renewed focus on the optimal role for immunotherapy in the frontline setting for patients with advanced non–small cell lung cancer (NSCLC), according to a talk by Solange Peters, MD, PhD, at the ESMO Immuno Oncology Congress.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication